Application Note: Development of a Multiplex High Throughput Screening Assay Cascade for Evaluating Receptor Tyrosine Kinase Binding and Activation
25 September 2012

Screening for protein based therapeutics that inhibit ligand binding and/or downstream activation events in living cells represents a powerful approach for the discovery of novel drugs. This scientific poster, presented at ELRIG Drug Discovery 2012, describes how IntelliCyt have developed a series of live-cell based screening assays for the HTFC® Screening System that addresses multiple steps in these ligand-receptor driven pathways. For these studies, interactions between EphA2 receptor and its ligands were used as a model system. The results demonstrate that high throughput flow cytometry can be leveraged to improve productivity in the drug discovery process.

Download PDF >>PDF Icon

Read the full article...

  Become a member
  • Quick and complete access to all application articles

  • Download 10,000+
    applications and methods

  • Make informed buying decisions


Already a member?

Log in for full access to the article




Remember me